A Study of MLN0264 in Patients With Pancreatic Cancer
Status:
Terminated
Trial end date:
2016-01-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of MLN0264 in
patients with advanced or metastatic guanylyl cyclase C (GCC)-positive adenocarcinoma of the
pancreas.